This product is not clubbable with other items in cart. Please remove this or other items to proceed further.
No Items In Cart
On August 6 and 7, 2019, USP hosted the Second Annual Workshop to explore current trends, initiatives and regulations for quality compounding. Members of the West Pharmaceutical Services, Inc. (West) Scientific Affairs and Strategic Marketing departments participated in the USP workshop and gained valuable insight into the key elements of the FDA’s efforts to improve the quality of compounded drugs.
Sara Rothman, Senior Policy Advisor with FDA’s Office of Unapproved Drugs and Labeling Compliance in the Center for Drug Evaluation and Research, Office of Compliance, presented the FDA’s perspective. Key takeaways from Sara’s presentation include:
West constantly stays abreast of the regulatory landscape in order to provide high-quality products and support to customers. For more information, please contact an Account Manager or Technical Customer Support (TCS) representative.
Take an in-depth look at the science behind containment & delivery of injectable medicines in the West Knowledge Center.